Multisite Evaluation of a Point-of-Care Instrument for CD4+ T-Cell Enumeration Using Venous and Finger-Prick Blood
Authors:
- Papa Alassane DiawPDPapa Alassane Diaw
- Géraldine DaneauGDGéraldine Daneau
- Abdoul Aziz ColyACAbdoul Aziz Coly
- Birahim Pierre NdiayeBNBirahim Pierre Ndiaye
- Djibril WadeDWDjibril Wade
- Makhtar CamaraMCMakhtar Camara
- Souleymane MboupSMSouleymane Mboup
- Luc KestensLKLuc Kestens
- Tandakha Ndiaye DieyeTDTandakha Ndiaye Dieye
- 1 December 2011
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 58 (4) , e103-e111
Abstract
BACKGROUND: CD4(+) T-cell enumeration (CD4 count) is used as a criterion to initiate antiretroviral therapy (ART) in HIV patients and to monitor treatment efficacy. However, simple, affordable, and reliable point-of-care (POC) instruments adapted to resource-limited settings are still lacking. The PIMA CD4 analyzer is a new POC instrument for CD4 counting that uses disposable cartridges and a battery-powered analyzer. METHODS: Whole blood samples were taken by venipuncture or by finger prick from 300 subjects, including HIV-infected patients and HIV (-) controls. CD4 counts were measured by PIMA (using venous or capillary blood) and by FACSCount (using venous blood) considered as the reference. RESULTS: Similar CD4 counts were obtained by PIMA and FACSCount using either HIV+ venous blood or HIV+ finger-prick blood samples. However, with a concordance coefficient of 0.88 and a Pearson correlation of 0.89, finger-prick blood performed not as good as venous blood (0.97 and 0.98, respectively). For a clinical decision to start ART at 200 CD4 cells per microliter, sensitivity of PIMA was 90%/91% and specificity 98%/96% for venous/finger-prick blood, respectively, and for a treatment threshold of 350 CD4 cells per microliter, the sensitivity was 98%/91% and the specificity was 79%/80% for venous/finger-prick blood, respectively. Repeatability (precision) on venous blood resulted in a coefficient of variation of 4%. Using finger-prick blood, the average instrument error frequency resulting in aborted analyses was 14%. CONCLUSIONS: PIMA is a good POC instrument for screening adult HIV-infected patients in resource-limited settings for treatment eligibility. Its performance on finger-prick blood is not as good as on venous blood. Adequate training for correct use of finger-prick blood samples is mandatoryKeywords
This publication has 13 references indexed in Scilit:
- Absolute and percent CD4+ T-cell enumeration by flow cytometry using capillary bloodJournal of Immunological Methods, 2011
- Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testingAIDS, 2011
- Evaluation of the PIMA Point-of-Care CD4 Analyzer in VCT Clinics in ZimbabweJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Affordable CD4 T-cell enumeration for resource-limited regions: A status report for 2008Cytometry Part B: Clinical Cytometry, 2008
- Evaluation of a single-platform microcapillary flow cytometer for enumeration of absolute CD4+ T-lymphocyte counts in HIV-1 infected Thai patientsCytometry Part B: Clinical Cytometry, 2007
- Validation of Primary CD4 Gating as an Affordable Strategy for Absolute CD4 Counting in CambodiaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- The Added Value of a CD4 Count to Identify Patients Eligible for Highly Active Antiretroviral Therapy Among HIV-Positive Adults in CambodiaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Absolute CD4 T-Cell Counting in Resource-Poor SettingsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Multiple method comparison: Statistical model using percentage similarityCytometry Part B: Clinical Cytometry, 2003
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960